332 related articles for article (PubMed ID: 25280384)
1. Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways.
Nazir N; Siddiqui K; Al-Qasim S; Al-Naqeb D
BMC Med Genet; 2014 Oct; 15():103. PubMed ID: 25280384
[TBL] [Abstract][Full Text] [Related]
2. Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.
Raina P; Sikka R; Gupta H; Matharoo K; Bali SK; Singh V; Bhanwer A
Biochem Genet; 2021 Aug; 59(4):966-996. PubMed ID: 33609191
[TBL] [Abstract][Full Text] [Related]
3. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.
Ahluwalia TS; Khullar M; Ahuja M; Kohli HS; Bhansali A; Mohan V; Venkatesan R; Rai TS; Sud K; Singal PK
PLoS One; 2009; 4(4):e5168. PubMed ID: 19357773
[TBL] [Abstract][Full Text] [Related]
4. Association of monocyte chemoattractant protein-1 2518G/A gene polymorphism with diabetic nephropathy risk.
Su N; Li HY; Huang MF; Jiang ZP; Zhou TB
J Recept Signal Transduct Res; 2015 Feb; 35(1):94-7. PubMed ID: 25051493
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression.
Hameed I; Masoodi SR; Malik PA; Mir SA; Ghazanfar K; Ganai BA
Gene; 2018 Jun; 661():51-59. PubMed ID: 29605608
[TBL] [Abstract][Full Text] [Related]
6. Genetic associations in diabetic nephropathy: a meta-analysis.
Mooyaart AL; Valk EJ; van Es LA; Bruijn JA; de Heer E; Freedman BI; Dekkers OM; Baelde HJ
Diabetologia; 2011 Mar; 54(3):544-53. PubMed ID: 21127830
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in
Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
[TBL] [Abstract][Full Text] [Related]
8. VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis.
Sun L; Yuan Q; Cao N; Guo W; Yao L; Feng JM; Ma JF; Wang LN
ScientificWorldJournal; 2014; 2014():624573. PubMed ID: 25184149
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy.
Tziastoudi M; Stefanidis I; Hadjigeorgiou GM; Stravodimos K; Zintzaras E
Clin Kidney J; 2017 Jun; 10(3):293-300. PubMed ID: 28616206
[No Abstract] [Full Text] [Related]
10. Meta-Analysis and Bioinformatics Detection of Susceptibility Genes in Diabetic Nephropathy.
Tziastoudi M; Cholevas C; Theoharides TC; Stefanidis I
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008447
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms of cytokine genes and diabetic nephropathy: A comprehensive systematic review and meta-analysis.
Wu J; Jiang C; Hua Y; Liu X; You C
Int J Clin Pract; 2021 Nov; 75(11):e14634. PubMed ID: 34309136
[TBL] [Abstract][Full Text] [Related]
12. The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.
Stefanidis I; Tziastoudi M; Tsironi EE; Dardiotis E; Tachmitzi SV; Fotiadou A; Pissas G; Kytoudis K; Sounidaki M; Ampatzis G; Mertens PR; Liakopoulos V; Eleftheriadis T; Hadjigeorgiou GM; Santos M; Zintzaras E
Ren Fail; 2018 Nov; 40(1):561-576. PubMed ID: 30353771
[TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide synthase gene polymorphisms and risk of diabetic nephropathy: a systematic review and meta-analysis.
Dellamea BS; Pinto LC; Leitão CB; Santos KG; Canani LH
BMC Med Genet; 2014 Jan; 15():9. PubMed ID: 24433471
[TBL] [Abstract][Full Text] [Related]
14. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy.
Pettigrew KA; McKnight AJ; Patterson CC; Kilner J; Sadlier DM; Maxwell AP
J Hum Genet; 2010 Apr; 55(4):248-51. PubMed ID: 20203694
[TBL] [Abstract][Full Text] [Related]
15. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
[TBL] [Abstract][Full Text] [Related]
16. The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies.
Tziastoudi M; Stefanidis I; Zintzaras E
Clin Kidney J; 2020 Oct; 13(5):768-781. PubMed ID: 33123356
[TBL] [Abstract][Full Text] [Related]
17. Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis.
Tziastoudi M; Theoharides TC; Nikolaou E; Efthymiadi M; Eleftheriadis T; Stefanidis I
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499658
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
Yu ZY; Chen LS; Zhang LC; Zhou TB
Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
[TBL] [Abstract][Full Text] [Related]
19. Association of angiotensin-converting enzyme insertion/deletion polymorphism with type 1 diabetic nephropathy: a meta-analysis.
Xu HY; Liu MM; Wang X; He XY
Ren Fail; 2016 Oct; 38(9):1320-1327. PubMed ID: 27498976
[TBL] [Abstract][Full Text] [Related]
20. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
